Publications

The anti-obesity drug revolution: a booming market

Article published in allnews on October 4, 2024

“Innovation is the key to success for pharmaceutical companies, whose leadership position can waver at any moment.”

At a time when obesity has become a global priority, pharmaceutical companies are racing to develop innovative solutions. Leaders such as Eli Lilly and Novo Nordisk currently dominate, but competition is intensifying and new molecules could change the game.

Read the commentary by Stéphanie Rheinboldt, Senior Equity Advisor, published in Allnews on October 4, 2024, in French : La course aux médicaments anti-obésité | Allnews

October 04, 2024

Publications

Letter from The CIO - December 2025

Investing with discipline: what 2025 has taught us

December 11, 2025

Publications

Swiss Economic Diplomacy in Transition

Multinational companies emerge as diplomatic actors, revealing a shifting hybrid economic governance.

December 01, 2025

Publications

Letter from the CIO - October 2025

Markets in Suspension: Between Euphoria and Caution

October 15, 2025